Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023303 · ClinicalTrials.gov registry record · NA
Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin
A NA study of Dermatologic Conditions, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06023303: Completed NA study of Dermatologic Conditions, sponsored by Cynosure.
NCT06023303 is a NA study of Dermatologic Conditions that has completed, run by Cynosure. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06023303, a NA study of Dermatologic Conditions, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
Primary Outcome
The maximum pain during treatment per each device will be reported on a scale of 0 (none) to 10 (maximum intolerable pain).
Conditions Studied
Interventions
- DEVICE Potenza
- DEVICE Morpheus
Study Locations (1)
Massachusetts
- Cynosure, Inc - Westford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-06-21 |
| Est. Completion | 2023-08-10 |
| Phase | NA |
What the finished NCT06023303 record still lists
NCT06023303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Dermatologic Conditions appearing as the primary indexed condition, and to 2 interventions - of which Potenza is the first listed.
NCT06023303 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06023303 about?
NCT06023303 is a clinical study titled "Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin". The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
What is the current status of trial NCT06023303?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-06-21. Estimated completion is 2023-08-10.
What conditions does trial NCT06023303 study?
This clinical trial studies the following conditions: Dermatologic Conditions.
What interventions are being tested in trial NCT06023303?
The interventions under investigation include: Potenza (DEVICE), Morpheus (DEVICE).
Who is sponsoring clinical trial NCT06023303?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06023303 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatologic Conditions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06023303's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI